IP Library Granted Patent US 9,138,417
Granted Patent B2
US 9,138,417 · App. 14/003,265 · Granted Sep 22, 2015

Controlled release particles and production method thereof

Inventor: Junji Oshima (Osaka, JP)
Assignee: OSAKA GAS CHEMICALS CO., LTD.
A61K9/5026A01N25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,417
App. No.
14/003,265
Granted
Sep 22, 2015
Kind
B2
Abstract

A controlled release particle includes a core containing an antibiotic compound, and a shell covering the core. The controlled release particle is obtained by a production method including a first step in which a first component containing an antibiotic compound and a polymerizable vinyl monomer is subjected to suspension polymerization to form the core containing the antibiotic compound and a polymer of the polymerizable vinyl monomer; and a second step in which a second component containing a shell-forming component is subjected to interfacial polymerization to form a shell, wherein in the second step, the interfacial polymerization is started simultaneously with the start of the suspension polymerization of the first step, or started after the start of the suspension polymerization of the first step.

Claims (11)

1. A controlled release particle comprising a core containing an antibiotic compound and a shell covering the core,

wherein the controlled release particle is obtained by a production method including

a first step in which a first component containing the antibiotic compound and a polymerizable vinyl monomer is subjected to suspension polymerization to form the core containing the antibiotic compound and a polymer of the polymerizable vinyl monomer, and

a second step in which a second component containing a shell-forming component is subjected to interfacial polymerization to form the shell,

wherein in the second step, the interfacial polymerization is started simultaneously with the start of the suspension polymerization of the first step, or started after the start of the suspension polymerization of the first step, and

wherein the antibiotic compound has a polar term δ p,compound of 2 to 8[(J/cm 3 ) 1/2 ]and a hydrogen bonding term δ h,compound of 5.5 to 9.5[(J/cm 3 ) 1/2 ] of a solubility parameter δ, and

the polymer has a polar term δ p,polymer of 5 to 7[(J/cm 3 1/2 ] and a hydrogen bonding term δ h,polymer of 8 to 10[(J/cm 3 ) 1/2 ] of the solubility parameter δ, the solubility parameter δ being defined by Hansen and calculated by van Krevelen and Hoftyzer method.

2. A method for producing a controlled release particle, the method including

a first step in which a first component containing an antibiotic compound and a polymerizable vinyl monomer is subjected to suspension polymerization to form a core containing the antibiotic compound and a polymer of the polymerizable vinyl monomer, and

a second step in which a second component containing a shell-forming component is subjected to interfacial polymerization to form a shell covering the core,

wherein in the second step, the interfacial polymerization is started simultaneously with the start of the suspension polymerization of the first step, or started after the start of the suspension polymerization of the first step.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jun 24, 2015
From: JAPAN ENVIROCHEMICALS, LTD.; OSAKA GAS CHEMICALS CO., LTD.
To: OSAKA GAS CHEMICALS CO., LTD.
Reel/Frame 035962/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2013
From: OSHIMA, JUNJI
To: JAPAN ENVIROCHEMICALS, LTD.
Reel/Frame 031140/0885 →
Priority Claims (2)
JP 2011-054627 · Mar 11, 2011 · national
JP 2012-037886 · Feb 23, 2012 · national
Continuity (1)
Related Publication 20130337072A1 · Dec 19, 2013